BioMarin Pharma (BMRN) Tops Q3 EPS by 13c, Revenue Misses

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. NRIX
6. SUNS
7. CRDO
8. OIG
9. SPY
10. SNDX

Go back to BioMarin Pharma (BMRN) Tops Q3 EPS by 13c, Revenue Misses

BioMarin Announces Third Quarter 2016 Financial Results

October 27, 2016 4:03 PM EDT

- Third Quarter 2016 Total BioMarin Revenues Increase 34% Year over Year to $280 million

- Vimizim Net Product Revenues Increase 25% Year over Year to $81 million in the Third Quarter 2016

- Kuvan Net Product Revenues Increase 42% Year over Year to $91 million in the Third Quarter 2016  

 Financial Highlights (in millions of U.S. dollars, except per share data, unaudited)

  Three Months Ended September... More